Open Access<p><em>NR5A2</em> Promotes Cell Growth and Resistance to Temozolomide Through Regulating Notch Signal Pathway in Glioma</p>
Author(s) -
Quanxi Yang,
Lei Hong Deng,
Jialiang Li,
Ping Miao,
Wenxiang Liu,
Qi Huang
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s243833
Subject(s) - glioma , cancer research , gene knockdown , temozolomide , notch signaling pathway , cell growth , downregulation and upregulation , viability assay , cell cycle , cell , flow cytometry , apoptosis , medicine , biology , signal transduction , microbiology and biotechnology , immunology , biochemistry , genetics , gene
Glioma is a fatal primary malignant tumor. We aimed to explore the effect of nuclear receptor subfamily 5 group A member 2 ( NR5A2 ) on glioma.